Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma

A Retrospective Study of Primary Tumor Characteristics

Stephen Luen, Wong Siew Wei, Victoria Mar, John W. Kelly, Catriona McLean, Grant A. McArthur, Andrew Haydon

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Stage IV melanoma exhibits a diverse range of tumor biology from indolent to aggressive disease. Many important prognostic factors have already been identified. Despite this, the behavior of metastatic melanoma remains difficult to predict. We sought to determine if any primary tumor characteristics affect survival following the diagnosis of stage IV melanoma.

METHODS: All patients diagnosed with stage IV melanoma between January 2003 and December 2012 were identified from the Victorian Melanoma Service database. Retrospective chart review was performed to collect data on primary tumor characteristics (thickness, ulceration, mitotic rate, melanoma subtype, or occult primary). Known and suspected prognostic factors were additionally collected (time to diagnosis of stage IV disease, age, sex, stage, receipt of chemotherapy, and era of recurrence). The effect of primary tumor characteristics on overall survival from the date of diagnosis of stage IV disease was assessed.

RESULTS: A total of 227 patients with a median follow-up of 5 years from diagnosis of stage IV disease were identified. Median overall survival of the cohort was 250 days.Of the primary tumor characteristics assessed, only tumor thickness affected survival from diagnosis of stage IV disease, hazard ratio=1.09 (1.02 to 1.16), P=0.008. This remained significant in multivariate analysis, P=0.007. Other primary tumor characteristics did not significantly influence survival.

CONCLUSIONS: Primary tumor thickness is a significant prognostic factor in stage IV melanoma. Our data suggest that the biology of the primary melanoma may persist to influence the behavior of metastatic disease.

Original languageEnglish (US)
Pages (from-to)90-94
Number of pages5
JournalAmerican Journal of Clinical Oncology
Volume41
Issue number1
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Melanoma
Retrospective Studies
Neoplasms
Survival
Multivariate Analysis
Databases
Recurrence
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma : A Retrospective Study of Primary Tumor Characteristics. / Luen, Stephen; Wei, Wong Siew; Mar, Victoria; Kelly, John W.; McLean, Catriona; McArthur, Grant A.; Haydon, Andrew.

In: American Journal of Clinical Oncology, Vol. 41, No. 1, 01.01.2018, p. 90-94.

Research output: Contribution to journalArticle

Luen, Stephen ; Wei, Wong Siew ; Mar, Victoria ; Kelly, John W. ; McLean, Catriona ; McArthur, Grant A. ; Haydon, Andrew. / Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma : A Retrospective Study of Primary Tumor Characteristics. In: American Journal of Clinical Oncology. 2018 ; Vol. 41, No. 1. pp. 90-94.
@article{70d124d3075549e8933a662a391894fe,
title = "Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics",
abstract = "INTRODUCTION: Stage IV melanoma exhibits a diverse range of tumor biology from indolent to aggressive disease. Many important prognostic factors have already been identified. Despite this, the behavior of metastatic melanoma remains difficult to predict. We sought to determine if any primary tumor characteristics affect survival following the diagnosis of stage IV melanoma.METHODS: All patients diagnosed with stage IV melanoma between January 2003 and December 2012 were identified from the Victorian Melanoma Service database. Retrospective chart review was performed to collect data on primary tumor characteristics (thickness, ulceration, mitotic rate, melanoma subtype, or occult primary). Known and suspected prognostic factors were additionally collected (time to diagnosis of stage IV disease, age, sex, stage, receipt of chemotherapy, and era of recurrence). The effect of primary tumor characteristics on overall survival from the date of diagnosis of stage IV disease was assessed.RESULTS: A total of 227 patients with a median follow-up of 5 years from diagnosis of stage IV disease were identified. Median overall survival of the cohort was 250 days.Of the primary tumor characteristics assessed, only tumor thickness affected survival from diagnosis of stage IV disease, hazard ratio=1.09 (1.02 to 1.16), P=0.008. This remained significant in multivariate analysis, P=0.007. Other primary tumor characteristics did not significantly influence survival.CONCLUSIONS: Primary tumor thickness is a significant prognostic factor in stage IV melanoma. Our data suggest that the biology of the primary melanoma may persist to influence the behavior of metastatic disease.",
author = "Stephen Luen and Wei, {Wong Siew} and Victoria Mar and Kelly, {John W.} and Catriona McLean and McArthur, {Grant A.} and Andrew Haydon",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/COC.0000000000000226",
language = "English (US)",
volume = "41",
pages = "90--94",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma

T2 - A Retrospective Study of Primary Tumor Characteristics

AU - Luen, Stephen

AU - Wei, Wong Siew

AU - Mar, Victoria

AU - Kelly, John W.

AU - McLean, Catriona

AU - McArthur, Grant A.

AU - Haydon, Andrew

PY - 2018/1/1

Y1 - 2018/1/1

N2 - INTRODUCTION: Stage IV melanoma exhibits a diverse range of tumor biology from indolent to aggressive disease. Many important prognostic factors have already been identified. Despite this, the behavior of metastatic melanoma remains difficult to predict. We sought to determine if any primary tumor characteristics affect survival following the diagnosis of stage IV melanoma.METHODS: All patients diagnosed with stage IV melanoma between January 2003 and December 2012 were identified from the Victorian Melanoma Service database. Retrospective chart review was performed to collect data on primary tumor characteristics (thickness, ulceration, mitotic rate, melanoma subtype, or occult primary). Known and suspected prognostic factors were additionally collected (time to diagnosis of stage IV disease, age, sex, stage, receipt of chemotherapy, and era of recurrence). The effect of primary tumor characteristics on overall survival from the date of diagnosis of stage IV disease was assessed.RESULTS: A total of 227 patients with a median follow-up of 5 years from diagnosis of stage IV disease were identified. Median overall survival of the cohort was 250 days.Of the primary tumor characteristics assessed, only tumor thickness affected survival from diagnosis of stage IV disease, hazard ratio=1.09 (1.02 to 1.16), P=0.008. This remained significant in multivariate analysis, P=0.007. Other primary tumor characteristics did not significantly influence survival.CONCLUSIONS: Primary tumor thickness is a significant prognostic factor in stage IV melanoma. Our data suggest that the biology of the primary melanoma may persist to influence the behavior of metastatic disease.

AB - INTRODUCTION: Stage IV melanoma exhibits a diverse range of tumor biology from indolent to aggressive disease. Many important prognostic factors have already been identified. Despite this, the behavior of metastatic melanoma remains difficult to predict. We sought to determine if any primary tumor characteristics affect survival following the diagnosis of stage IV melanoma.METHODS: All patients diagnosed with stage IV melanoma between January 2003 and December 2012 were identified from the Victorian Melanoma Service database. Retrospective chart review was performed to collect data on primary tumor characteristics (thickness, ulceration, mitotic rate, melanoma subtype, or occult primary). Known and suspected prognostic factors were additionally collected (time to diagnosis of stage IV disease, age, sex, stage, receipt of chemotherapy, and era of recurrence). The effect of primary tumor characteristics on overall survival from the date of diagnosis of stage IV disease was assessed.RESULTS: A total of 227 patients with a median follow-up of 5 years from diagnosis of stage IV disease were identified. Median overall survival of the cohort was 250 days.Of the primary tumor characteristics assessed, only tumor thickness affected survival from diagnosis of stage IV disease, hazard ratio=1.09 (1.02 to 1.16), P=0.008. This remained significant in multivariate analysis, P=0.007. Other primary tumor characteristics did not significantly influence survival.CONCLUSIONS: Primary tumor thickness is a significant prognostic factor in stage IV melanoma. Our data suggest that the biology of the primary melanoma may persist to influence the behavior of metastatic disease.

UR - http://www.scopus.com/inward/record.url?scp=85039561717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039561717&partnerID=8YFLogxK

U2 - 10.1097/COC.0000000000000226

DO - 10.1097/COC.0000000000000226

M3 - Article

VL - 41

SP - 90

EP - 94

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -